1Ausems MG,Ten Berg K,Kroos MA,et al.Glycogen storage disease type I:birth prevalence agrees with predicted genotype frequency.Community Genet,1999,2:91-96.
2Mah C,Gresawn KO,Fraites TJ,et al.Sustained correction of glycogen storage disease type Ⅱ using adeno-associated virus serotype 1 vectors.Gene Ther,2005,12:1405-1409.
3Gresawn KO,Fraites TJ,Wasserfall C,et al.Impact of humoral immune response on distribution and efficacy of recombinant adenoassociated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type Ⅱ.Hum Gene Ther,2005,16:68-80.
